Shaukat Ali

2PUBLICATIONS
0CO-AUTHORS
Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Nov 09, 2022
Phase II/III trial of hyperimmune anti-COVID-19 intravenous immunoglobulin (C-IVIG) therapy in severe COVID-19 patients: study protocol for a randomized controlled trial.

Shaukat Ali, Elisha Shalim, Farah Farhan

|Feb 09, 2021
Production of hyperimmune anti-SARS-CoV-2 intravenous immunoglobulin from pooled COVID-19 convalescent plasma.

Shaukat Ali, Syed M Uddin, Ayesha Ali

Pageof 1

Frequent Collaborators